跳至主要内容
临床试验/NL-OMON52052
NL-OMON52052招募中不适用

PHARMACOKINETICS OF APREPITANT, DEXAMETHASONE AND THEIR INTERACTION IN PATIENTS WITH CHEMOTHERAPY INDUCED NAUSEA AND VOMITING - PHARMACOKINETICS OF APREPITANT, DEXAMETHASONE AND THEIR INTERACTIO

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Planned to receive chemotherapy intravenously as regular treatment (standard
  • 2. Receiving dexamethasone with or without aprepitant as standard of care
  • 3. Receiving the chemotherapy and anti-emetics during hospitalized treatment.
  • 4. Age >=18;
  • 5. Signed Informed consent form (ICF) prior to participation in the study;
  • 6. Able and willing to undergo blood draw for the study (two different days, 6
  • times per day) and does not have any condition that makes participation
  • disadvantageous.
  • 7. For women: not pregnant
  • 8. No use of strong CYP3A4 substrates or inhibitors within 7 days or CYP3A4
  • inducers within 30 days of treatment (appendix 2);

排除标准

  • See inclusion criteria

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验